1. Home
  2. TXG vs KRYS Comparison

TXG vs KRYS Comparison

Compare TXG & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$63.80

Market Cap

8.5B

Sector

Industrials

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$341.72

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
KRYS
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
9.6B
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
TXG
KRYS
Price
$63.80
$341.72
Analyst Decision
Hold
Strong Buy
Analyst Count
15
11
Target Price
$20.25
$297.60
AVG Volume (30 Days)
3.0M
306.8K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
76.97
128.00
EPS
N/A
3.62
Revenue
$245,893,000.00
$389,130,000.00
Revenue This Year
N/A
$38.74
Revenue Next Year
$7.33
$32.53
P/E Ratio
N/A
$95.74
Revenue Growth
68.06
33.94
52 Week Low
$11.17
$143.09
52 Week High
$65.47
$382.54

Technical Indicators

Market Signals
Indicator
TXG
KRYS
Relative Strength Index (RSI) 71.19 51.36
Support Level $17.54 $253.89
Resistance Level N/A $382.33
Average True Range (ATR) 3.95 9.76
MACD 0.67 1.66
Stochastic Oscillator 93.26 76.93

Price Performance

Historical Comparison
TXG
KRYS

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: